We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » MOTION Trial Will Pit Boniva Against Fosamax
MOTION Trial Will Pit Boniva Against Fosamax
September 26, 2005
Roche and GlaxoSmithKline (GSK) are raising the stakes in the osteoporosis drug market, announcing Sept. 26 they will launch a clinical trial pitting their new monthly osteoporosis treatment Boniva against Pfizer’s Fosamax, the current market leader.